COVID-19 : Impact on Research and Clinical Trials Globally and Risk for People with ALS/MND
On Thursday, April 9th a webinar with leading ALS/MND Global Clinicians and Researchers took place. COVID-19 and its impacts to the ALS/MND Community have been felt globally. This webinar answers your questions about susceptibility and ALS/MND, care, and the impacts to research and clinical trials. The link to view the recording can be found below.
Moderator: David Taylor
Panelists:
- Dr. Merit Cudkowicz
- Dr. Angela Genge
- Dr. Jonathan Glass
- Dr. Matthew Kiernan
- Dr. Leonard van den Berg
Click on the image below for questions and answers from this webinar.
NEALS Webinar: Impact of Covid-19 on ALS Clinical Research
NEALS Webinar: Impact of COVID-19 on ALS clinical research from Northeast ALS Consortium on Vimeo.
COVID-19 Webinar
On Thursday, April 9th a webinar with leading ALS/MND Global Clinicians and Researchers took place. COVID-19 and its impacts to the ALS/MND Community have been felt globally. This webinar answers your questions about susceptibility and ALS/MND, care, and the impacts to research and clinical trials. The link to view the recording can be found below.
Moderator: David Taylor
Panelists:
- Dr. Merit Cudkowicz
- Dr. Angela Genge
- Dr. Jonathan Glass
- Dr. Matthew Kiernan
- Dr. Leonard van den Berg
Orphazyme Community Statement and FAQs
Orphazyme Community Statement – Dr. Thomas Blaettler, Chief Medical Officer – March 2020
FAQs Related to the Clinical Development of Arimoclomol in ALS During the COVID-19 Pandemic